The Heptagon Fund provides proof of concept funding for its seven partners for new technologies in life sciences and healthcare. The Fund addresses the translation of novel and inventive ideas from fundamental research to commercial demonstration, leading to soundly based propositions able to attract licensing deals or investment funding. 

The seven partners are:

Queen Mary, University of London (lead)
King’s College London
University of Kent
The Royal Veterinary College
The School of Pharmacy
Birkbeck and
St George’s Hospital Medical School. 

The Heptagon Fund was awarded �2 million funding under HEIF2 in August 2004.